Developers: | Rhaeos |
Date of the premiere of the system: | October, 2020 |
Branches: | Pharmaceutics, medicine, health care |
2020: The announcement of FlowSense - a smart plaster for control of removal of cerebrospinal fluid
In the middle of October, 2020 the American company Rhaeos released a smart plaster for control of removal of cerebrospinal fluid at patients with brain dropsy. It is supposed that the noninvasive plaster of FlowSense will allow to control passability of a drainage and in time to announce serious complications at its fault.
At patients with hydrocephaly or dropsy of a brain the excess of cerebrospinal fluid which needs to be taken away via the ventricular shunt is formed. However these shunts regularly fail that can lead to zhizneugrozhayushchy complications. Before an easy way to check operability of the shunt did not exist, and doctors usually used MPT/KT a brain to estimate passability of a drainage. However these procedures of visualization not only are inconvenient and expensive, but also can lead to considerable radiation of the patient at regular inspections.
To solve this problem, the Rhaeos company provided the FlowSense device, the noninvasive plaster developed by John Rogers's laboratory in Northwestern University. In this smart plaster the small heater which softly increases skin temperature directly over the shunt is used, and then precisely takes this temperature in points of entry and an exit. In the absence of a drainage temperature of skin increases equally in all directions around the heater. But when cerebrospinal fluid moves on the shunt, warmly around the heater changes unevenly, with small, but measurable temperature increase is lower on a flow. The smart plaster uses high-precision temperature sensors and Bluetooth technology for sending these data for the mobile device which analyzes a flow and transfers result to the doctor.[1]